Results 291 to 300 of about 256,322 (306)

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial

Lancet, The, 2018
Arun J Sanyal, Edgar D Charles, Brent A Neuschwander-Tetri   +2 more
exaly  

Fibroblast Growth Factor Receptor 4

2020
openaire   +1 more source

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

New England Journal of Medicine, 2008
Orlando M Gutiérrez, Michael Mannstadt, Tamara Isakova   +2 more
exaly  

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

New England Journal of Medicine, 2003
Yasuo Imanishi, Geeta Hampson, Michael J Econs   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Fibroblast growth factor receptor (FGFR)

Science-Business eXchange, 2014
openaire   +1 more source

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Circulation, 2009
Orlando M Gutiérrez, James L Januzzi, Tamara Isakova   +2 more
exaly  

Fibroblast growth factor signalling: from development to cancer

Nature Reviews Cancer, 2010
Nicholas Turner, Richard Grose
exaly  

Fibroblast growth factor-23 and Klotho in chronic kidney disease

Kidney International Supplements, 2011
Marc G Vervloet
exaly  

Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice

Circulation, 2015
Zhuofeng Lin, Xuebo Pan, Fan Wu
exaly